Tanke Biosciences Corporation booked $28.6M in FY2012 revenue, growing 20% year over year — faster than most Financial Services companies we track, at a -0.7% net margin.
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.